Bispecific Antibodies Expose Tumors to New Lines of Attack

Genetic Engineering & Biotechnology NewsVol. 43, No. 5 Cancer ResearchBispecific Antibodies Expose Tumors to New Lines of AttackBy exploiting dual specificity to ever greater effect, bispecific antibodies expand possibilities for Treg depletion, checkpoint inhibition, and targeted toxicityAmanda HeidtAmanda HeidtSearch for more papers by this authorPublished Online:8 May 2023https://doi.org/10.1089/gen.43.05.08AboutSectionsView articleView Full TextPDF/EPUB Permissions & CitationsPermissionsDownload CitationsTrack CitationsAdd to favorites Back To Publication ShareShare onFacebookTwitterLinked InRedditEmail View articleFiguresReferencesRelatedDetails Volume 43Issue 5May 2023 Information© 2023 by GEN PublishingTo cite this article:Amanda Heidt.Bispecific Antibodies Expose Tumors to New Lines of Attack.Genetic Engineering & Biotechnology News.May 2023.26-28, 31.http://doi.org/10.1089/gen.43.05.08Published in Volume: 43 Issue 5: May 8, 2023PDF download